EPA and DHA omega-3s from food and supplements may reduce the risk of coronary heart disease (CHD), according to results of a new meta-analysis.
Data from 18 randomized clinical trials (RCTs) indicated that EPA and DHA were associated with a non-statistically significant 6% risk reduction in CHD among all populations, while the risk reduction increased to a statistically significant 18% when data from 16 prospective cohort studies was assessed.
A trial reported in 2016 indicates that supplementation with omega 3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can help improve major depression.
The study shows that both high levels of EPA+DHA at baseline and supplementation with these two omega 3 fatty acids result in favorable post-treatment outcomes in major depression patients.
When it comes to diet, brain health, and Alzheimer disease, what’s the deal? Is there evidence that you are what you eat when it comes to brain health?
Over the past several years, the development of evidence and scientific progress has been astounding. There are two different types of nutritional categories [that have been gaining attention]. One is the type of dietary pattern that someone follows—for example, the Mediterranean-style diet or ketogenic diet. Second, I’m sure you’ve heard about caloric restriction and even, most recently, the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. Continue reading “Diet and Cognitive Decline: Untangling the Evidence”
Blood levels of DHA and other omega-3s are directly related to measures of cognition and behavior in schoolchildren with below average reading ability, says a new study from the UK. Continue reading “Oxford University study: Omega-3 Levels Linked to Improved Cognition and Behavior in Schoolchildren”
The potential brain health benefits of increased intake of DHA at birth may take several years to emerge, according to data from a small cohort of children. Continue reading “DHA’s Brain Health Benefits May Emerge in Later Childhood”